Cargando…

The Development of Nanoparticles for the Detection and Imaging of Ovarian Cancers

Ovarian cancer remains as one of the most lethal gynecological cancers to date, with major challenges associated with screening, diagnosis and treatment of the disease and an urgent need for new technologies that can meet these challenges. Nanomaterials provide new opportunities in diagnosis and the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henderson, Edward, Huynh, Gabriel, Wilson, Kirsty, Plebanski, Magdalena, Corrie, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615601/ https://www.ncbi.nlm.nih.gov/pubmed/34829783 http://dx.doi.org/10.3390/biomedicines9111554

Ejemplares similares

Natural Compounds with Potential to Modulate Cancer Therapies and Self-Reactive Immune Cells
por: Moody, Rhiane, et al.
Publicado: (2020)

Sperm Protein 17 Expression by Murine Epithelial Ovarian Cancer Cells and Its Impact on Tumor Progression
por: Gao, Qian, et al.
Publicado: (2018)

Montanide, Poly I:C and nanoparticle based vaccines promote differential suppressor and effector cell expansion: a study of induction of CD8 T cells to a minimal Plasmodium berghei epitope
por: Wilson, Kirsty L., et al.
Publicado: (2015)

A Nanoparticle Based Sp17 Peptide Vaccine Exposes New Immuno-Dominant and Species Cross-reactive B Cell Epitopes
por: Xiang, Sue D., et al.
Publicado: (2015)

Regulatory T Cells in Ovarian Carcinogenesis and Future Therapeutic Opportunities
por: Cassar, Emily, et al.
Publicado: (2022)

Adaptive Immunity and the Risk of Autoreactivity in COVID-19
por: Moody, Rhiane, et al.
Publicado: (2021)

Non-Invasive Fluorescent Monitoring of Ovarian Cancer in an Immunocompetent Mouse Model
por: Wilson, Amy L., et al.
Publicado: (2018)

Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer
por: Kampan, Nirmala Chandralega, et al.
Publicado: (2015)

Potential Impact of Human Cytomegalovirus Infection on Immunity to Ovarian Tumours and Cancer Progression
por: Cox, Momodou, et al.
Publicado: (2021)

Pullulan-Coated Iron Oxide Nanoparticles for Blood-Stage Malaria Vaccine Delivery
por: Powles, Liam, et al.
Publicado: (2020)

A Model to Study the Impact of Polymorphism Driven Liver-Stage Immune Evasion by Malaria Parasites, to Help Design Effective Cross-Reactive Vaccines
por: Wilson, Kirsty L., et al.
Publicado: (2016)

Functional Recognition by CD8+ T Cells of Epitopes with Amino Acid Variations Outside Known MHC Anchor or T Cell Receptor Recognition Residues
por: Wilson, Kirsty L., et al.
Publicado: (2020)

Mapping Epitopes Recognised by Autoantibodies Shows Potential for the Diagnosis of High-Grade Serous Ovarian Cancer and Monitoring Response to Therapy for This Malignancy
por: Moody, Rhiane, et al.
Publicado: (2021)

DPP4 Inhibitor Sitagliptin Enhances Lymphocyte Recruitment and Prolongs Survival in a Syngeneic Ovarian Cancer Mouse Model
por: Wilson, Amy L., et al.
Publicado: (2021)

Dendritic Cells and Myeloid Derived Suppressor Cells Fully Responsive to Stimulation via Toll-Like Receptor 4 Are Rapidly Induced from Bone-Marrow Cells by Granulocyte-Macrophage Colony-Stimulating Factor
por: Kong, Ying Ying, et al.
Publicado: (2020)

Biodegradable PLGA-b-PEG Nanoparticles Induce T Helper 2 (Th2) Immune Responses and Sustained Antibody Titers via TLR9 Stimulation
por: Wilson, Kirsty L., et al.
Publicado: (2020)

Chemoresistance is mediated by ovarian cancer leader cells in vitro
por: Karimnia, Nazanin, et al.
Publicado: (2021)

Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8(+) T Cell Responses
por: Xiang, Sue D., et al.
Publicado: (2018)

A Synthetic Nanoparticle Based Vaccine Approach Targeting MSP4/5 Is Immunogenic and Induces Moderate Protection Against Murine Blood-Stage Malaria
por: Wilson, Kirsty L., et al.
Publicado: (2019)

Antioxidant-Based Medicinal Properties of Stingless Bee Products: Recent Progress and Future Directions
por: Al-Hatamleh, Mohammad A. I., et al.
Publicado: (2020)

Imaging and therapy of ovarian cancer: clinical application of nanoparticles and future perspectives
por: Di Lorenzo, Giovanni, et al.
Publicado: (2018)

Magnetic Nanovectors for the Development of DNA Blood-Stage Malaria Vaccines
por: Al-Deen, Fatin M. Nawwab, et al.
Publicado: (2017)

Elevated Interleukin-6 Levels in the Circulation and Peritoneal Fluid of Patients with Ovarian Cancer as a Potential Diagnostic Biomarker: A Systematic Review and Meta-Analysis
por: Amer, Hina, et al.
Publicado: (2021)

Active Ratio Test (ART) as a Novel Diagnostic for Ovarian Cancer
por: Kang, Sung-Woog, et al.
Publicado: (2021)

Hypoxia Regulates DPP4 Expression, Proteolytic Inactivation, and Shedding from Ovarian Cancer Cells
por: Moffitt, Laura R., et al.
Publicado: (2020)

A Novel Approach for Non-Invasive Lung Imaging and Targeting Lung Immune Cells
por: Chakraborty, Amlan, et al.
Publicado: (2020)

Review: Nanomaterials for Reactive Oxygen Species Detection and Monitoring in Biological Environments
por: Huynh, Gabriel T., et al.
Publicado: (2021)

Therapeutic Cancer Vaccines—T Cell Responses and Epigenetic Modulation
por: Kartikasari, Apriliana E. R., et al.
Publicado: (2019)

Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis
por: Kartikasari, Apriliana E. R., et al.
Publicado: (2021)

A Novel Predictive Multi-Marker Test for the Pre-Surgical Identification of Ovarian Cancer
por: Stephens, Andrew N., et al.
Publicado: (2023)

Nanoparticle-Based Combination Therapy for Ovarian Cancer
por: Wu, Yingli, et al.
Publicado: (2023)

Keratin-14 (KRT14) Positive Leader Cells Mediate Mesothelial Clearance and Invasion by Ovarian Cancer Cells
por: Bilandzic, Maree, et al.
Publicado: (2019)

Development of Peptide Vaccines in Dengue
por: Reginald, Kavita, et al.
Publicado: (2018)

Predicted B Cell Epitopes Highlight the Potential for COVID-19 to Drive Self-Reactive Immunity
por: Moody, Rhiane, et al.
Publicado: (2021)

Substantially Modified Ratios of Effector to Regulatory T Cells During Chemotherapy in Ovarian Cancer Patients Return to Pre-Treatment Levels at Completion: Implications for Immunotherapy
por: Park, Anthony, et al.
Publicado: (2012)

Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system
por: Bound, Nirashaa T., et al.
Publicado: (2022)

The Use of Synthetic Carriers in Malaria Vaccine Design
por: Powles, Liam, et al.
Publicado: (2015)

Pre-operative sera interleukin-6 in the diagnosis of high-grade serous ovarian cancer
por: Kampan, Nirmala Chandralega, et al.
Publicado: (2020)

Developing Protein-Based Nanoparticles as Versatile Delivery Systems for Cancer Therapy and Imaging
por: Sandra, Febrina, et al.
Publicado: (2019)

The detection, treatment, and biology of epithelial ovarian cancer
por: Gubbels, Jennifer AA, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_b4gskgh0uo3q6759d534r8avct